In Other News

• Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients

• Advanced Endoscopy Platform Recognized for Third Space Procedures

• Blood Gene Signature Differentiates Major Depressive Disorder

• AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development

• Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

• Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

• At-Home Blood and Cognitive Tests Support Dementia Risk Stratification

• Patented Isothermal Amplification Chemistry Advances Decentralized Testing

• Biomarkers and Molecular Testing Advance Precision Allergy Care

• Finger-Prick Blood Test Aids Early Tuberculosis Detection and Risk Stratification

• Urine Test Beats MRI in Identifying Prostate Cancer Upgrading During Active Surveillance

• Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing

• Direct-to-Patient Genetic Testing Identifies Hereditary Cancer Risk in Survivors

• Telomere Length Abnormalities Linked to Lymphoma Development

• Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia

• Genomic Testing Program Improves Diagnosis of Congenital Hyperinsulinism

• Stool DNA Analysis Tracks Disease Activity in IBD

• Automated Workflow and AI Tool Enhance Latent TB Testing and Risk Stratification

• Ultrasonic Fine-Needle Biopsy Tool Improves Salivary Gland Tumor Diagnosis

• Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

• Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer

• Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio

• Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response